Plasma and muscle tissue disposition of enrofloxacin in Nile tilapia (Oreochromis niloticus) after intravascular, intraperitoneal, and oral administrations
 
Yazarlar (11)
Prof. Dr. Orhan Çorum University Of Hatay Mustafa Kemal, Türkiye
Doç. Dr. Ertuğrul TERZİ Kastamonu Üniversitesi, Türkiye
Doç. Dr. Duygu Durna Çorum University Of Hatay Mustafa Kemal, Türkiye
Arş. Gör. Dr. Yiğit TAŞTAN Kastamonu Üniversitesi, Türkiye
Ruby C Gonzales
Mindanao State University At Naawan, Filipinler
Arş. Gör. Dr. Osman Nezih KENANOĞLU Kastamonu Üniversitesi, Türkiye
Dan M Arriesgado
Mindanao State University At Naawan, Filipinler
Victor R Navarro
Mindanao State University At Naawan, Filipinler
Doç. Dr. Soner BİLEN Kastamonu Üniversitesi, Türkiye
Doç. Dr. Adem Yavuz SÖNMEZ Kastamonu Üniversitesi, Türkiye
Prof. Dr. Kamil Üney Selçuk Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Food Additives and Contaminants Part A (Q2)
Dergi ISSN 1944-0049 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 09-2022
Kabul Tarihi 28-08-2022 Yayınlanma Tarihi 22-09-2022
Cilt / Sayı / Sayfa 39 / 11 / 1806–1817 DOI 10.1080/19440049.2022.2121429
Makale Linki http://dx.doi.org/10.1080/19440049.2022.2121429
UAK Araştırma Alanları
Su Ürünleri Yetiştiriciliği Su Ürünleri Hastalıkları
Özet
The aim of the study was to investigate the plasma and muscle pharmacokinetic of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) in Nile tilapia (Oreochromis niloticus) following single intravascular (IV), intraperitoneal (IP), or oral (PO) administration at 30 ± 1 °C. In this study, 234 healthy Nile tilapia (120–150 g) were used. The fish received a single IV, IP, or PO treatment of ENR at a dose of 10 mg/kg. The plasma and muscle tissue concentrations of ENR and CIP were measured using high–performance liquid chromatography with fluorescence detection and were evaluated using non–compartmental analysis. The elimination half–life, volume of distribution at steady state, and total body clearance of ENR were 21.7 h, 2.69 L/kg, and 0.09 L/h/kg, respectively. The peak plasma concentrations of ENR after IP or PO administration were 6.11 and 4.21 µg/mL at 0.25 and 2 h, respectively. The …
Anahtar Kelimeler
bioavailability | enrofloxacin | muscle tissue | Pharmacokinetics | rainbow trout